![Peter Wijngaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Peter L.
J.
Wijngaard is the founder of Corsera Health, Inc. Former jobs include Chairman at Aurinia Pharmaceuticals, Inc. from 2011 to 2013, Independent Director at Hepion Pharmaceuticals, Inc. from 2020 to 2023, Director at Ciclofilin Pharmaceuticals, Inc. from 2014 to 2016, Director-Global Alliance at Hoffmann-La Roche, Inc., Independent Non-Executive Director at Isotechnika Pharma, Inc. from 2011 to 2013, and VP-Innovation Leader Research & Development at The Medicines Company (Schweiz) GmbH.
Education includes a doctorate from the University of Utrecht conferred in 1992.
Anciens postes connus de Peter Wijngaard
| Sociétés | Poste | Fin |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 04/12/2023 |
The Medicines Company (Schweiz) GmbH | Corporate Officer/Principal | 01/01/2020 |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Directeur/Membre du Conseil | 01/06/2016 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Directeur/Membre du Conseil | 23/10/2013 |
Formation de Peter Wijngaard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
The Medicines Company (Schweiz) GmbH | |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
